Results of the a phase III clinical trial called EMBER-3 indicate the promise and efficacy of a drug called imlunestrant. This is a new kind of oral selective estrogen receptor degrader (SERD), used ...
Breast implant illness (BII) is an emerging concern among women with implants, leading many to opt for explant surgery to alleviate symptoms and regain their health. Dr.